GE HealthCare’s first quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, buoyed by robust ...

Cardiac PET combined with CT is rapidly expanding despite artifactual defects and false-positive results due to misregistration of PET and CT attenuation correction data—the frequency, cause, and ...

Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological ...

To investigate the prognostic value of peri-tumoral radiomics features of pre-treatment PET/CT images in patients with head and neck cancer. 166 patients from 4 centers (111 for training and 55 for ...

Starting with a 28 or 35 cm axial FOV, a 76 cm large gantry bore, and 700 lbs. table load capacity, uMI Panorama advances PET/CT imaging for patients of all sizes.

LOUISVILLE, Ky. (AP) — GE Appliances announced a nearly half-billion-dollar project Thursday that it says will create 800 new jobs and shift production of clothes washers from China to its ...

The US Food and Drug Administration (FDA) has expanded the indications of an imaging agent developed by GE HealthCare, which will likely put it at the forefront of the Alzheimer’s diagnostics arena.

GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has approved an updated label for its positron emission tomography (PET) imaging agent Vizamyl TM ...

Compatible with GEHC’s Omni Legend PET/CT and other systems, the agent is designed to support detailed assessment of myocardial perfusion, ischemia, and infiltrative cardiomyopathies.

GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...